Antifungal activity of Zuccagnia punctata Cav.: Evidence for the mechanism of action

Planta Medica

Volumn 73, Issue 10, 2007, Pages 1074-1080

  Svetaz, Laura ^a   Agüero, María Belén ^b   Alvarez, Sandra ^a   Luna, Lorena ^b   Feresin, Gabriela ^b   Derita, Marcos ^a   Tapia, Alejandro ^b   Zacchino, Susana ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b Instituto Geofísico Sismológico Ing F Volponi   (Argentina)

Author keywords

Antifungal; Bioautography; Chalcones; Densitometry; Fabaceae; Mechanism of action; Zuccagnia punctata

Indexed keywords

2',4' DIHYDROXY 3' METHOXYCHALCONE; 2',4' DIHYDROXYCHALCONE; AMPHOTERICIN B; CHALCONE DERIVATIVE; DICHLOROMETHANE; ECHINOCANDIN; PETROLEUM; PLANT EXTRACT; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; ZUCCAGNIA PUNCTATA EXTRACT;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; DERMATOPHYTE; ETHNOPHARMACOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTIFUNGAL AGENTS; FABACEAE; FRUIT; HUMANS; MICROBIAL SENSITIVITY TESTS; MITOSPORIC FUNGI; PHYTOTHERAPY; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; PLANT ROOTS;

ARTHRODERMATACEAE; FABACEAE; FUNGI; ZUCCAGNIA PUNCTATA;

EID: 34548619116     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981561     Document Type: Article

References (28)

1. Kontoyiannis D, Mantadakis E, Samonis G. Systemic mycoses in the immunocompromised host: an update in antifungal therapy. J Hosp Infect 2003; 53: 243-58.
2. Patterson T. Advances and challenges in management of invasive mycoses. Lancet 2005; 366: 1013-5.
3. Ablordeppey S, Fan P, Ablordeppey J, Mardenborough L. Systemic antifungal agents against AIDS-related opportunistic infections: current status and emerging drugs in development. Curr Med Chem 1999; 6: 1151-95.
4. Odds F, Motyl M, Andrade R, Bille J, Cantón E, Cuenca-Estrella M et al. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol 2004; 42: 3475-82.
5. Kiesling R. Flora de San Juan, Vol. 1. Buenos Aires: Vazquez Manzini; 1994: 286.
6. Burkart A. Las leguminosas argentinas silvestres y cultivadas.; 2a Ed Buenos Aires: ACME Agency; 1952: 184-5
7. Del Vitto L, Petenatti E, Petenatti M. Recursos herbolarios de San Luis (República Argentina). Primera parte: plantas nativas. Multequina 1997; 6: 49-66.
8. Alcaraz LE, Blanco SE, Puig ON, Tomás F, Ferreti FH. Antibacterial activity of flavonoids against methicillin-resistant Staphylococcus aureus strains. J Theor Biol 2000; 205: 231-40.
9. Zampini IC, Vattuone MA, Isla MI. Antibacterial activity of Zuccagnia punctata Cav. ethanolic extracts. J Ethnopharmacol 2005; 102: 450-6.
10. Quiroga EN, Sampietro AR, Vattuone MA. Screening for antifungal activities of selected medicinal plants. J Ethnopharmacol 2001; 74: 89-96.
11. Svetaz L, Tapia A, López SN, Furlán RLE, Petenatti E, Pioli R et al. Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi. J Agric Food Chem 2004; 52: 3297-300.
12. Pederiva R, Giordano O. 3,7-Dihydroxy-8-methoxyflavone from Zuccagnia punctata. Phytochemistry 1984; 23: 1340-1.
13. Pederiva R, Kavka J, D'Arcangelo A. Chalconas y flavanonas aisladas de Larrea nítida Cav. An Asoc Quím Argentina 1975; 63: 85-90.
14. NCCLS. National Committee for Clinical and Laboratory Standards. Method M-27-A2 for yeasts. 2002: Vol. 22(15); 1-29.
15. NCCLS and method M-38A for filamentous fungi. 2002; 22(16): 1-27.
16. Wright LR, Scott EM, Gorman SP. The sensitivity of mycelium, arthrospores, and microconidia of Trichophyton mentagrophytes to imidazoles determined by in vitro tests. J Antimicrob Chemother 1983; 12: 317-27.
17. Rahalison L, Hamburger M, Hostettmann K, Monod M, Frenk E. A bioautographic agar overlay method for the detection of antifungal compounds from higher plants. Phytochem Anal 1991; 2: 199-203.
18. Saxena G, Farmer S, Towers GHN, Hancock REW. Use of specific dyes in the detection of antimicrobial compounds from crude plant extracts using a thin layer chromatography agar overlay technique. Phytochem Anal 1995; 6: 125-9.
19. Frost D, Brandt K, Cugier D, Goldman R. A whole cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly. J Antibiot 1995; 48: 306-10.
20. Carson CF, Mee BJ, Riley TV. Mechanism of action of Melaleuca alternifolia (Tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage and salt tolerance assays and electron microscopy. Antimicrob Agents Chemother 2002; 46: 1914-20.
21. Lunde C, Kubo I. Effect of polygodial on the mitochondrial ATPase of Saccharomyces cerevisiae. Antimicrob Agents Chemother 2000; 44: 1943-53.
22. Ernst E, Roling E, Petzold R, Keele D, Klepser M. In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies. Antimicrob Agents Chemother 2002; 46: 3846-53.
23. Almirante B, Rodríguez D, Park B, Cuenca-Estrella M, Planes A, Amela L et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, 2002-2003. J Clin Microbiol 2005; 43: 1829-35.
24. Singh N. Treatment of opportunistic mycoses: how long is long enough? Lancet Infect Dis 2003; 3: 703-8.
25. Weitzmann I, Summerbell R. The dermatophytes. Clin Microb Rev 1995; 8: 240-59.
26. López S, Castelli MV, Zacchino SA, Domínguez J, Lobo G, Charris J et al. In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. Bioorg Med Chem 2001; 9: 1999-2013.
27. Groll A, De Lucca A, Walsh T. Emerging targets for the development of novel antifungal therapeutics. Trends Microbiol 1998; 6: 117-23.
28. Di Domenico B. Novel antifungal drugs. Curr Opin Microbiol 1999; 2: 509-15.